Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Neuropharmacology ; 83: 79-88, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24721625

RESUMO

Nandrolone decanoate, an anabolic androgen steroid (AAS) illicitly used by adult and adolescent athletes to enhance physical performance and body image, induces psychiatric side effects, such as aggression, depression as well as a spectrum of adverse physiological impairments. Since adolescence represents a neurodevelopmental window that is extremely sensitive to the detrimental effects of drug abuse, we investigated the long-term behavioral and neurophysiological consequences of nandrolone abuse during adolescence. Adolescent rats received daily injections of nandrolone decanoate (15 mg/kg, i.m.) for 14 days (PND 40-53). At early adulthood (PND 68), forced swim, sucrose preference, open field and elevated plus maze tests were performed to assess behavioral changes. In vivo electrophysiological recordings were carried out to monitor changes in electrical activity of serotonergic neurons of the dorsal raphe nucleus (DRN) and noradrenergic neurons of the locus coeruleus (LC). Our results show that after early exposure to nandrolone, rats display depression-related behavior, characterized by increased immobility in the forced swim test and reduced sucrose intake in the sucrose preference test. In addition, adult rats presented anxiety-like behavior characterized by decreased time and number of entries in the central zone of the open field and decreased time spent in the open arms of the elevated plus maze. Nandrolone decreased the firing rate of spontaneously active serotonergic neurons in the DRN while increasing the firing rate of noradrenergic neurons in the LC. These results provide evidence that nandrolone decanoate exposure during adolescence alters the emotional profile of animals in adulthood and significantly modifies both serotonergic and noradrenergic neurotransmission.


Assuntos
Neurônios Adrenérgicos/efeitos dos fármacos , Anabolizantes/toxicidade , Ansiedade/induzido quimicamente , Depressão/induzido quimicamente , Núcleo Dorsal da Rafe/efeitos dos fármacos , Nandrolona/análogos & derivados , Neurônios Serotoninérgicos/efeitos dos fármacos , Transmissão Sináptica/efeitos dos fármacos , Potenciais de Ação/efeitos dos fármacos , Neurônios Adrenérgicos/fisiologia , Fatores Etários , Anabolizantes/administração & dosagem , Animais , Ansiedade/fisiopatologia , Comportamento Animal/efeitos dos fármacos , Núcleo Dorsal da Rafe/fisiologia , Masculino , Nandrolona/administração & dosagem , Nandrolona/toxicidade , Decanoato de Nandrolona , Ratos , Ratos Sprague-Dawley , Neurônios Serotoninérgicos/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA